AGEAS 75.850 € (-1,30 %) WDP 20.660 € (-1,99 %) EKOPAK 3.550 € (-1,53 %) AB INBEV 67.600 € (-1,57 %) VGP 71.700 € (-1,38 %) DEME GROUP 180.800 € (-0,88 %) SHURGARD 23.650 € (+1,28 %) RETAIL ESTATES 64.600 € (-0,77 %) MONTEA 63.500 € (-1,55 %) AEDIFICA 65.600 € (-0,68 %) ONWARD MEDICAL 2.895 € (+0,17 %) RECTICEL 12.580 € (-2,93 %) KINEPOLIS GROUP 49.700 € (-0,10 %) FAGRON 21.950 € (-1,13 %) EVS 27.500 € (-1,96 %) GIMV 46.300 € (-0,86 %) UMICORE 21.680 € (-2,34 %) KBC 131.100 € (-1,72 %) TITAN S.A. 48.300 € (-2,74 %) ECONOCOM GROUP 1.470 € (-1,34 %) MELEXIS 66.400 € (+1,45 %) ARGENX SE 871.400 € (+0,39 %) PROXIMUS 6.240 € (-5,45 %) BREDERODE 105.600 € (0,00 %) IMMOBEL 19.050 € (-1,80 %) BARCO 7.230 € (-2,36 %) VAN DE VELDE 29.700 € (-0,67 %) NYXOAH 1.310 € (-2,82 %) CFE 10.500 € (-1,41 %) OPTION 4.220 € (+8,21 %) ORANGE BELGIUM 22.000 € (-0,45 %) IBA 15.240 € (-0,13 %) WERELDHAVE BELGIUM 49.900 € (+0,20 %) ELIA GROUP 120.700 € (-1,07 %) CAMPINE 186.000 € (0,00 %) ONTEX GROUP 2.120 € (-0,93 %) ACCENTIS 0.026 € (0,00 %) SYENSQO 77.350 € (-1,09 %) DECEUNINCK 2.480 € (-0,60 %) FLUXYS BELGIUM D 22.100 € (0,00 %) BPOST 1.200 € (-1,64 %) HOME INVEST BE. 17.840 € (-1,11 %) TINC 11.020 € (-1,08 %) SOFINA 246.400 € (-1,36 %) ASCENCIO 52.500 € (-0,94 %) JENSEN-GROUP 75.400 € (-0,79 %) CARE PROPERTY INV. 12.400 € (-1,74 %) GBL 73.850 € (-1,27 %) AZELIS GROUP 12.010 € (-1,07 %) TESSENDERLO 20.500 € (-2,38 %) XIOR 25.200 € (-0,59 %) BIOTALYS 1.980 € (+0,81 %) SOLVAY 25.140 € (-4,41 %) MATERIALISE 6.750 € (-2,17 %) UCB 208.100 € (-0,24 %) KBC ANCORA 94.000 € (-1,26 %) BEKAERT 37.450 € (-1,83 %) CENERGY 22.020 € (+1,47 %) BELYSSE GROUP 0.420 € (-4,55 %) ACKERMANS V.HAAREN 271.400 € (-0,95 %)
LVMH 402.800 € (-2,30 %)
PROSUS 35.850 € (+0,17 %)
L'OREAL 376.050 € (-1,07 %)
VINCI 110.800 € (-1,86 %)
AXA 44.730 € (-0,73 %)
HERMES INTL 1 331.500 € (-3,16 %)
SANOFI 74.050 € (-1,61 %)
DANONE 60.540 € (-1,37 %)
BNP PARIBAS ACT.A 100.740 € (-2,93 %)
SAINT GOBAIN 69.120 € (-1,73 %)
AHOLD DEL 31.600 € (-1,22 %)
AIRBUS 193.380 € (-1,08 %)
AIR LIQUIDE 163.160 € (-1,26 %)
SCHNEIDER ELECTRIC 285.750 € (-0,47 %)
NEXITY 5.255 € (-3,58 %)
ALTAREA 85.300 € (-0,70 %)
WOLTERS KLUWER 68.160 € (-2,74 %)
PERNOD RICARD 59.440 € (-1,13 %)
SHELL PLC 41.315 € (-0,59 %)
UBISOFT ENTERTAIN 5.308 € (-2,61 %)
EUROFINS SCIENT. 76.440 € (-0,57 %)
MYHOTELMATCH 0.125 € (+16,90 %)
AKZO NOBEL 56.080 € (-0,74 %)
CSG 15.432 € (-4,07 %)
ALSTOM 15.280 € (-2,64 %)
VINPAI 2.600 € (-18,75 %)
CEGEDIM 10.500 € (-0,19 %)
MAUREL ET PROM 8.270 € (0,00 %)
EXAIL TECHNOLOGIES 124.500 € (0,00 %)
GECINA 65.500 € (-1,43 %)
SES 4.758 € (-3,25 %)
VIVENDI SE 1.493 € (-2,61 %)
ASM INTERNATIONAL 813.800 € (+2,91 %)
ARCELORMITTAL SA 63.120 € (-3,69 %)
DASSAULT SYSTEMES 20.560 € (-0,10 %)
MICHELIN 33.080 € (-1,37 %)
LEGRAND 135.800 € (-0,37 %)
CHRISTIAN DIOR 369.200 € (-2,17 %)
PHARMING GROUP 0.917 € (-2,28 %)
EUTELSAT COMMUNIC. 1.753 € (-2,99 %)
CAPGEMINI 104.350 € (-2,57 %)
LAKEFRONT BIOTHER. 24.980 € (+0,16 %)
2CRSI 28.360 € (-1,39 %)
HOPIUM 0.004 € (+2,94 %)
EURAZEO 46.420 € (-0,85 %)
HAFFNER ENERGY BSA 0.010 € (-20,83 %)
CREDIT AGRICOLE 18.190 € (-2,23 %)
EXOR NV 68.500 € (-4,06 %)
MAAT PHARMA 1.630 € (-18,50 %)
CORBION 22.660 € (+0,98 %)
ADP 108.300 € (-0,37 %)
ENGIE 24.030 € (-0,91 %)
MERCIALYS 10.480 € (-2,24 %)
BE SEMICONDUCTOR 186.650 € (+2,84 %)
CATERING INTL SCES 21.800 € (+9,55 %)
IMERYS 22.440 € (-0,88 %)
BOUYGUES 43.380 € (-3,28 %)
BRUNEL INTERNAT 7.220 € (-0,55 %)
UMG 14.750 € (+0,07 %)
ACOMO 23.000 € (-1,08 %) News Réglementées
|
09/09/2026 09:00
Original-Research: Emerald Horizon AG (von NuWays AG): BUYOriginal-Research: Emerald Horizon AG - from NuWays AG Classification of NuWays AG to Emerald Horizon AG
ADES Test Loop with VDL moves into execution First project-specific ADES agreement strengthens industrialisation path. Emerald Horizon (SMRX) yesterday officially kicked off the Test Loop programme for ADES, Emerald's accelerator-driven subcritical SMR, together with industrial partner VDL Groep at its LaboraTHorium in Graz. Importantly, the parties signed a project-specific agreement for the Test Loop under their long-term framework covering the development of ADES and TESS, marking the first project-specific agreement for an ADES Loop under the broader cooperation framework. The megawatt-scale Loop will now be developed with VDL in Eindhoven as a further step towards the fully integrated ADES prototype targeted for 2029. Testing and industrial design now progress in parallel. Following four previous Loop generations developed and tested by Emerald in Graz, the new megawatt-scale Loop represents the first Loop programme undertaken together with industrial partner VDL. Building on the results of the previous iterations, the programme will further validate the interaction of key fluid-thermodynamic components and systems, including the pump, molten-salt circulation, piping, heat exchanger, instrumentation and controls, while VDL incorporates the resulting engineering findings into the design. The objective is therefore not only further system validation, but also to translate Emerald's development work into an industrially manufacturable and scalable design. VDL involvement extends into co-development and industrialisation. While Emerald retains system leadership and reactor-physics development in Graz, VDL will contribute engineering, manufacturing, assembly and supply-chain expertise in Eindhoven. According to management, VDL will also commit its own resources to the programme, reflecting its involvement from the development stage. Importantly, involving VDL's manufacturing specialists already during design should incorporate manufacturability and scalability from the outset, while using VDL's existing industrial infrastructure supports Emerald's asset-light industrialisation strategy. Roadmap unchanged; execution now key. The current Test Loop is expected to run for c. 12–18 months (eNuW), with a further Loop expected ahead of the fully integrated ADES prototype targeted for 2029, followed by industrial serial production from 2031. Hence, yesterday's kick-off does not change our financial estimates or ADES deployment assumptions. However, the transition from the broader VDL cooperation framework into project-specific execution represents an important development and industrialisation milestone, with successful Loop validation expected to further de-risk the development path. We reiterate BUY with an unchanged €1,300 PT. ADES remains the main source of SMRX's long-term value potential. In our view, successful execution of the Test Loop should progressively increase confidence in the development roadmap towards the fully integrated prototype and subsequent industrialisation. You can download the research here: emerald-horizon-ag-2026-09-09-update-en-3689e For additional information visit our website: https://www.nuways-ag.com/research Contact for questions: NuWays AG - Equity Research Web: www.nuways-ag.com Email: research@nuways-ag.com LinkedIn: https://www.linkedin.com/company/nuwaysag Adresse: Mittelweg 16-17, 20148 Hamburg, Germany ++++++++++ Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss bestimmter Börsengeschäfte. Offenlegung möglicher Interessenkonflikte nach § 85 WpHG beim oben analysierten Unternehmen befindet sich in der vollständigen Analyse. ++++++++++ The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. 2396194 09.09.2026 CET/CEST Source : Webdisclosure.com |
||||||||||||||||||
© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière